Dexlansoprazole: delayed-release orally disintegrating tablets for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease and the maintenance of erosive esophagitis Article

sustainable development goals

authors

publication date

  • October 1, 2016

webpage

published in

keywords

  • Dexilant
  • Dexlansoprazole
  • erosive esophagitis
  • gastroesophageal reflux disease
  • non-erosive reflux disease
  • proton pump inhibitor

start page

  • 1083

end page

  • 1089

volume

  • 10

issue

  • 10